Current Size: 100%


LBG Weinherbst

As a science policy forum the Ludwig Boltzmann Gesellschaft (LBG) asked  for the first time researchers, policy makers and journalists to get together for the "Weinherbst" on the 20th Floor of the new Raiffeisen building in the heart of Vienna. The impressive panorama presented the backdrop for an inspiring meeting of science and research community. President of LBG Josef Pröll and science and research minister Univ.-Prof. Dr. Karlheinz Töchterle welcomed the numerous guests.


Workshop on Advances in Myeloproliferative Neoplasms

International experts in the area of myeloproliferative disease presented partly unpublished results ranging from basic research of molecular genetics to the study of mechanisms of neoplastic transformation and evolution of myeloproliferative disorders. In accordance with "Bench to Bedside" strategies and the value of new molecular targets for novel therapeutic approaches clinicians and biomedical scientists discussed thier results. Special attention was paid to the neoplastic cells of myeloproliferative diseases, and especially also the mast cell leukemias, which are now also assigned to the myeloproliferative disorders.

Invited Speaker Seminar: Next Generation Sequencing transforms health research

Andreas Sommer, head of genomics at the Campus Support Facility (CSF), gave an introduction to the tecnological advances in modern genetics and highlighted the capabilities and options available to external researchers. At a subseqent get together members of the LBI-CR explored access to the facilities and discussed differernt technological options. All in all the Seminar provided a stimulating reminder to include modern genomics technologies into the research approaches of the LBI-CR.

Moriggl gives talk at Aflac Research Conference, Atlanta

Prof. Kevin Bunting and Richard Moriggl met at Emory University. Image: LBI-CR

The Aflac Cancer and Blood Disorders Center of  Emory University is one of the leading pediatric cancer, hematology, and blood and marrow transplant (BMT) programs in the US. As such it provides advanced diagnostic and clinical care, as well as innovative treatment and research options to children, adolescents and young adults.

Dr. Richard Moriggl gave a presentation at the Aflac Leukemia/Lymphoma group meeting entitled:

"Gene dosage of STAT5 alters lymphocyte development and cancer progression with a key role for the CD8 T cell lineage"